Matches in Nanopublications for { <http://www.w3.org/1999/02/22-rdf-syntax-ns#OBJECT> ?p ?o ?g. }
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "patients present with secondary organising pneumonia ( OP ) given that corticosteroid therapy is the first-line treatment" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "a great promise in reducing mortality rates in COVID-19 patients" provenance.
- OBJECT label "to lower risk of mortality with an odds ratio ( OR ) of 0.85 ( 95 % CrI" provenance.
- OBJECT label "to lower risk of mortality with an odds ratio ( OR ) of 0.85 ( 95 % CrI" provenance.
- OBJECT label "to lower risk of mortality with an odds ratio ( OR ) of 0.85 ( 95 % CrI" provenance.
- OBJECT label "to lower risk of mortality with an odds ratio ( OR ) of 0.85 ( 95 % CrI" provenance.
- OBJECT label "to improve, after pancreatic ductal adenocarcinoma ( PDAC ) resection" provenance.
- OBJECT label "to improve, after pancreatic ductal adenocarcinoma ( PDAC ) resection" provenance.
- OBJECT label "to improve, after pancreatic ductal adenocarcinoma ( PDAC ) resection" provenance.
- OBJECT label "to improve, after pancreatic ductal adenocarcinoma ( PDAC ) resection" provenance.
- OBJECT label "to improve, after pancreatic ductal adenocarcinoma ( PDAC ) resection" provenance.
- OBJECT label "to improve, after pancreatic ductal adenocarcinoma ( PDAC ) resection" provenance.
- OBJECT label "reduce mortality in severe cases, further supporting a role for inflammation in disease severity" provenance.
- OBJECT label "reduce mortality in severe cases, further supporting a role for inflammation in disease severity" provenance.
- OBJECT label "reduce mortality in severe cases, further supporting a role for inflammation in disease severity" provenance.
- OBJECT label "reduce mortality in severe cases, further supporting a role for inflammation in disease severity" provenance.
- OBJECT label "reduce mortality in severe cases, further supporting a role for inflammation in disease severity" provenance.
- OBJECT label "reduce mortality in severe cases, further supporting a role for inflammation in disease severity" provenance.
- OBJECT label "reduce mortality in severe cases, further supporting a role for inflammation in disease severity" provenance.
- OBJECT label "tissue inflammation" provenance.
- OBJECT label "tissue inflammation" provenance.
- OBJECT label "tissue inflammation" provenance.
- OBJECT label "tissue inflammation" provenance.
- OBJECT label "the process of exocytosis" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.
- OBJECT label "clinical efficacythrough randomized controlled trials ( RCTs ) in seriously ill patients" provenance.